Matt Britz
Amministratore Delegato presso Affyimmune Therapeutics, Inc.
Posizioni attive di Matt Britz
Società | Posizione | Inizio | Fine |
---|---|---|---|
Affyimmune Therapeutics, Inc.
Affyimmune Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Affyimmune Therapeutics, Inc. engages in the development of engineered immune cells to fight cancer disease. The company was founded by Gang Song on August 16, 2016 and is headquartered in Natick, MA. | Amministratore Delegato | 19/03/2024 | - |
Direttore operativo | 01/01/2022 | - | |
Corporate Officer/Principal | 01/06/2021 | 01/01/2022 | |
Presidente | 01/06/2021 | 19/03/2024 |
Storia della carriera di Matt Britz
Formazione di Matt Britz
University of Massachusetts | Undergraduate Degree |
Washington University in St. Louis | Graduate Degree |
Statistiche
Distribuzione geografica
Stati Uniti | 4 |
Posizioni
Chief Executive Officer | 1 |
Chief Operating Officer | 1 |
Corporate Officer/Principal | 1 |
Settori
Consumer Services | 3 |
Commercial Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Aziende private | 1 |
---|---|
Affyimmune Therapeutics, Inc.
Affyimmune Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Affyimmune Therapeutics, Inc. engages in the development of engineered immune cells to fight cancer disease. The company was founded by Gang Song on August 16, 2016 and is headquartered in Natick, MA. | Commercial Services |
- Borsa valori
- Insiders
- Matt Britz
- Esperienza